• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病成人的生活质量:非酒精性脂肪性肝炎临床研究网络的基线数据。

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.

作者信息

David Kristin, Kowdley Kris V, Unalp Aynur, Kanwal Fasiha, Brunt Elizabeth M, Schwimmer Jeffrey B

机构信息

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, La Jolla, CA 92103, USA.

出版信息

Hepatology. 2009 Jun;49(6):1904-12. doi: 10.1002/hep.22868.

DOI:10.1002/hep.22868
PMID:19434741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2692572/
Abstract

UNLABELLED

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States. The association between NAFLD and quality of life (QOL) remains unclear. These data are important to estimate the burden of illness in NAFLD. The aim was to report QOL scores of adults with NAFLD and examine the association between NAFLD severity and QOL. QOL data were collected from adults with NAFLD enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network using the Short Form 36 (SF-36) survey, and scores were compared with normative U.S. population scores. Liver biopsy histology was reviewed by a central pathology committee. A total of 713 subjects with NAFLD (male = 269, female = 444) were included. Mean age of subjects was 48.3 years; 61% had definite nonalcoholic steatohepatitis (NASH), and 28% had bridging fibrosis or cirrhosis. Diabetes was present in 27% of subjects. Subjects with NAFLD had worse physical (mean, 45.2) and mental health scores (mean, 47.6) compared with the U.S. population with (mean, 50) and without (physical, 55.8; mental, 52.5) chronic illness. Subjects with NASH reported lower physical health compared with subjects with fatty liver disease without NASH (44.5 versus 47.1, P = 0.02). Subjects with cirrhosis had significantly (P < 0.001) poorer physical health scores (38.4) than subjects with no (47.6), mild (46.2), moderate (44.6), or bridging fibrosis (44.6). Cirrhosis was associated with poorer physical health after adjusting for potential confounders. Mental health scores did not differ between participants with and without NASH or by degree of fibrosis.

CONCLUSION

Adults with NAFLD have a significant decrement in QOL. Treatment of NAFLD should incorporate strategies to improve QOL, especially physical health.

摘要

未标注

非酒精性脂肪性肝病(NAFLD)是美国最常见的慢性肝病。NAFLD与生活质量(QOL)之间的关联仍不明确。这些数据对于评估NAFLD的疾病负担很重要。目的是报告NAFLD成人的生活质量得分,并研究NAFLD严重程度与生活质量之间的关联。使用简短健康调查问卷(SF - 36)从参加非酒精性脂肪性肝炎临床研究网络的NAFLD成人中收集生活质量数据,并将得分与美国正常人群得分进行比较。肝活检组织学由中央病理委员会进行审查。共纳入713例NAFLD患者(男性269例,女性444例)。受试者的平均年龄为48.3岁;61%患有明确的非酒精性脂肪性肝炎(NASH),28%有桥接纤维化或肝硬化。27%的受试者患有糖尿病。与患有慢性疾病(平均得分50)和未患慢性疾病(身体得分55.8;心理得分52.5)的美国人群相比,NAFLD患者的身体(平均得分45.2)和心理健康得分(平均得分47.6)更差。与无NASH的脂肪性肝病患者相比,NASH患者报告的身体健康状况更低(44.5对47.1,P = 0.02)。与无纤维化(47.6)、轻度纤维化(46.2)、中度纤维化(44.6)或桥接纤维化(44.6)的受试者相比,肝硬化患者的身体健康得分显著更低(P < 0.001,38.4)。在调整潜在混杂因素后,肝硬化与较差的身体健康相关。有和无NASH的参与者之间或按纤维化程度划分的心理健康得分没有差异。

结论

NAFLD成人的生活质量有显著下降。NAFLD的治疗应纳入改善生活质量的策略,尤其是身体健康方面。

相似文献

1
Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.非酒精性脂肪性肝病成人的生活质量:非酒精性脂肪性肝炎临床研究网络的基线数据。
Hepatology. 2009 Jun;49(6):1904-12. doi: 10.1002/hep.22868.
2
The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States.美国非酒精性脂肪性肝病成年患者中,多种药物治疗对生活质量的影响。
Qual Life Res. 2022 Aug;31(8):2481-2491. doi: 10.1007/s11136-022-03090-6. Epub 2022 Jan 22.
3
Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.体育活动建议、运动强度与非酒精性脂肪性肝病的组织学严重程度
Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469. doi: 10.1038/ajg.2010.488. Epub 2011 Jan 4.
4
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.美国非酒精性脂肪性肝炎相关肝硬化的患病率:基于国家健康与营养检查调查数据的分析
Am J Gastroenterol. 2017 Apr;112(4):581-587. doi: 10.1038/ajg.2017.5. Epub 2017 Feb 14.
5
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病成人的临床、实验室和组织学关联。
Hepatology. 2010 Sep;52(3):913-24. doi: 10.1002/hep.23784.
6
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.代谢综合征与非酒精性脂肪性肝病患儿肝组织学的关系。
Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.
7
Ethnicity and nonalcoholic fatty liver disease.种族与非酒精性脂肪性肝病。
Hepatology. 2012 Mar;55(3):769-80. doi: 10.1002/hep.24726.
8
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.全球非酒精性脂肪性肝病(NASH)/非酒精性脂肪性肝病(NAFLD)患者的临床和患者报告结局:来自全球非酒精性脂肪性肝炎(NASH)/非酒精性脂肪性肝病(NAFLD)注册中心的数据。
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2296-2306.e6. doi: 10.1016/j.cgh.2021.11.004. Epub 2021 Nov 9.
9
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.非酒精性脂肪性肝病(NAFLD)中的门静脉慢性炎症:非酒精性脂肪性肝炎临床研究网络的晚期NAFLD组织学标志物——临床病理相关性
Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724.
10
ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.ADH1B∗2 与非酒精性脂肪性肝病严重程度降低相关,与酒精摄入无关。
Gastroenterology. 2020 Sep;159(3):929-943. doi: 10.1053/j.gastro.2020.05.054. Epub 2020 May 23.

引用本文的文献

1
Value-Based Pricing of Resmetirom for Metabolic Dysfunction-Associated Steatotic Liver Disease.用于代谢功能障碍相关脂肪性肝病的resmetirom的基于价值的定价。
JAMA Netw Open. 2025 Jun 2;8(6):e2517122. doi: 10.1001/jamanetworkopen.2025.17122.
2
Cost-effectiveness analysis of duodenal-jejunal bypass sleeve device for people with obesity.十二指肠空肠旁路套筒装置用于肥胖人群的成本效益分析。
Health Econ Rev. 2025 Apr 8;15(1):32. doi: 10.1186/s13561-025-00623-w.
3
Effects of combined prebiotic fiber supplementation and weight loss counseling in adults with metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial.联合补充益生元纤维与体重减轻咨询对代谢功能障碍相关脂肪性肝病成人患者的影响:一项随机对照试验。
Eur J Nutr. 2025 Apr 2;64(4):144. doi: 10.1007/s00394-025-03660-7.
4
Metabolic dysfunction-associated steatotic liver disease in adults.成人代谢功能障碍相关脂肪性肝病
Nat Rev Dis Primers. 2025 Mar 6;11(1):14. doi: 10.1038/s41572-025-00599-1.
5
Status and factors influencing health-related quality of life in patients with non-alcoholic fatty liver disease in Hangzhou: a cross-sectional study.杭州非酒精性脂肪性肝病患者健康相关生活质量的现状及影响因素:一项横断面研究
BMJ Open. 2025 Mar 5;15(3):e088357. doi: 10.1136/bmjopen-2024-088357.
6
The impact of time-restricted eating on health-related quality of life: a systematic literature review.限时进食对健康相关生活质量的影响:一项系统文献综述。
Nutr Rev. 2025 Feb 1;83(2):230-248. doi: 10.1093/nutrit/nuae044.
7
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom.非酒精性脂肪性肝病患者的健康相关生活质量:西班牙和英国之间的跨文化研究。
PLoS One. 2024 May 6;19(5):e0300362. doi: 10.1371/journal.pone.0300362. eCollection 2024.
8
Association of the habitual dietary intake with the fatty liver index and effect modification by metabotypes in the population-based KORA-Fit study.基于人群的 KORA-Fit 研究中习惯性饮食摄入与脂肪肝指数的关联及代谢表型的影响修饰。
Lipids Health Dis. 2024 Apr 4;23(1):99. doi: 10.1186/s12944-024-02094-0.
9
Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者随机化移动技术生活方式方案的实施。
Sci Rep. 2024 Mar 28;14(1):7452. doi: 10.1038/s41598-024-57722-7.
10
Review and expert opinion on MAFLD, oxidative stress and multifunctional management.关于非酒精性脂肪性肝炎、氧化应激与多功能管理的综述及专家意见
Drugs Context. 2024 Jan 10;13. doi: 10.7573/dic.2023-9-3. eCollection 2024.

本文引用的文献

1
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.美国胃肠病学实践中新诊断慢性肝病的流行病学:基于人群监测的结果
Am J Gastroenterol. 2008 Nov;103(11):2727-36; quiz 2737. doi: 10.1111/j.1572-0241.2008.02071.x. Epub 2008 Jul 31.
2
Fatigue as a major predictor of quality of life in women with autoimmune liver disease: the case of primary biliary cirrhosis.疲劳是自身免疫性肝病女性生活质量的主要预测指标:以原发性胆汁性肝硬化为例。
Womens Health Issues. 2008 Jul-Aug;18(4):336-42. doi: 10.1016/j.whi.2007.12.005. Epub 2008 Apr 16.
3
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4).基于健康相关生活质量预测2型糖尿病患者的死亡率(ZODIAC-4研究)
Diabetes Care. 2008 May;31(5):932-3. doi: 10.2337/dc07-2072. Epub 2008 Mar 4.
4
Health-related quality of life in chronic hepatitis B patients.慢性乙型肝炎患者的健康相关生活质量
Hepatology. 2008 Apr;47(4):1108-17. doi: 10.1002/hep.22138.
5
Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.非酒精性脂肪性肝病(NAFLD)中的疲劳很显著,且与缺乏运动和日间过度嗜睡相关,但与肝病严重程度或胰岛素抵抗无关。
Gut. 2008 Jun;57(6):807-13. doi: 10.1136/gut.2007.139303. Epub 2008 Feb 12.
6
Effect of symptomatic gastroesophageal reflux disease on quality of life of patients with chronic liver disease.症状性胃食管反流病对慢性肝病患者生活质量的影响。
Hepatol Res. 2008 Apr;38(4):335-9. doi: 10.1111/j.1872-034X.2007.00275.x. Epub 2007 Nov 16.
7
Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation.脂肪肝疾病对普通人群医疗服务利用及费用的影响:一项为期5年的观察研究
Gastroenterology. 2008 Jan;134(1):85-94. doi: 10.1053/j.gastro.2007.10.024. Epub 2007 Oct 18.
8
Health-related quality of life in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的健康相关生活质量
Aliment Pharmacol Ther. 2007 Sep 15;26(6):815-20. doi: 10.1111/j.1365-2036.2007.03426.x.
9
Factors influencing change in health-related quality of life after liver transplantation.肝移植术后影响健康相关生活质量变化的因素。
Clin Transplant. 2007 Jul-Aug;21(4):481-99. doi: 10.1111/j.1399-0012.2007.00672.x.
10
Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy.中国轻微肝性脑病患者健康相关生活质量的评估
World J Gastroenterol. 2007 Jun 7;13(21):3003-8. doi: 10.3748/wjg.v13.i21.3003.